Diabetes Mellitus is chronic hyperglycaemia that damages blood vessels long before symptoms appear. Indonesia ranks 5th worldwide (IDF 2021) with 19.5 million patients.
Classification (ADA 2024): Type 1 (autoimmune, insulin required), Type 2 (90–95%, linked to central obesity), Gestational, LADA, and MODY.
Diagnosis: Fasting glucose ≥126 mg/dL, 2-hour OGTT ≥200, or HbA1c ≥6.5%. HbA1c target for adults: <7%.
Modern control: education, low-glycaemic-index nutrition, 150 min/week physical activity, medications (metformin, GLP-1, SGLT-2, insulin), plus CGM and insulin-pump technology.
Prime Lab offers a comprehensive diabetes screening package from Rp 275,000 including HbA1c, lipid profile, and full urinalysis.